Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs F5 Inc (FFIV) Price & Performance

BioNTech SE - ADRTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs F5 Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while F5 Inc trades at $414 (market cap $23.44B). The key difference: BioNTech SE - ADR and F5 Inc are close in size by market cap, and F5 Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.

BNTXFFIV
Market Cap
$23.31B$23.44B
Sector
HealthTechnology
52-Week High
$119.34$431.26
52-Week Low
$83.89$223.99
Enterprise Value
$6.60B$22.08B

Returns comparison

Trailing returns across standard periods

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About F5 Inc

F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.

Read more on FFIV